18F-DOPA II - PET Imaging Optimization

Clinical trial NCT04706910 · RECRUITING

Trial details

NCT number: NCT04706910
Sponsor: University of Alberta
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Congenital Hyperinsulinism Neuroblastoma Parkinson Disease Lewy Body Disease Neuroendocrine Tumors Brain Tumor

Start date: 2021-01-20
Primary completion: 2027-12-01
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.